These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 7701192)

  • 21. Modafinil : A Review of its Pharmacology and Clinical Efficacy in the Management of Narcolepsy.
    McClellan KJ; Spencer CM
    CNS Drugs; 1998 Apr; 9(4):311-24. PubMed ID: 27521015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modafinil: a second look. Confirmed efficacy in narcolepsy.
    Prescrire Int; 1999 Feb; 8(39):5-7. PubMed ID: 10557564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy.
    Black J; Pardi D; Hornfeldt CS; Inhaber N
    Sleep Med; 2009 Sep; 10(8):829-35. PubMed ID: 19616998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of modafinil on wakefulness and executive function in patients with narcolepsy experiencing late-day sleepiness.
    Schwartz JR; Nelson MT; Schwartz ER; Hughes RJ
    Clin Neuropharmacol; 2004; 27(2):74-9. PubMed ID: 15252267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the abuse liability of modafinil and other drugs for excessive daytime sleepiness associated with narcolepsy.
    Jasinski DR; Kovacević-Ristanović R
    Clin Neuropharmacol; 2000; 23(3):149-56. PubMed ID: 10895398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological management of narcolepsy with and without cataplexy.
    Kallweit U; Bassetti CL
    Expert Opin Pharmacother; 2017 Jun; 18(8):809-817. PubMed ID: 28443381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severe mania complicating treatment of narcolepsy with cataplexy.
    Crosby MI; Bradshaw DA; McLay RN
    J Clin Sleep Med; 2011 Apr; 7(2):214-6. PubMed ID: 21509339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging treatments for narcolepsy and its related disorders.
    Nishino S; Okuro M
    Expert Opin Emerg Drugs; 2010 Mar; 15(1):139-58. PubMed ID: 20166851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin.
    Morgenthaler TI; Kapur VK; Brown T; Swick TJ; Alessi C; Aurora RN; Boehlecke B; Chesson AL; Friedman L; Maganti R; Owens J; Pancer J; Zak R;
    Sleep; 2007 Dec; 30(12):1705-11. PubMed ID: 18246980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of modafinil on excessive daytime sleepiness in Prader-Willi syndrome.
    De Cock VC; Diene G; Molinas C; Masson VD; Kieffer I; Mimoun E; Tiberge M; Tauber M
    Am J Med Genet A; 2011 Jul; 155A(7):1552-7. PubMed ID: 21671379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacotherapy for excessive daytime sleepiness.
    Banerjee D; Vitiello MV; Grunstein RR
    Sleep Med Rev; 2004 Oct; 8(5):339-54. PubMed ID: 15336235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prader-Willi syndrome, excessive daytime sleepiness, and narcoleptic symptoms: a case report.
    Weselake SV; Foulds JL; Couch R; Witmans MB; Rubin D; Haqq AM
    J Med Case Rep; 2014 Apr; 8():127. PubMed ID: 24742112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of clinical characteristics among narcolepsy with and without cataplexy and idiopathic hypersomnia without long sleep time, focusing on HLA-DRB1( *)1501/DQB1( *)0602 finding.
    Sasai T; Inoue Y; Komada Y; Sugiura T; Matsushima E
    Sleep Med; 2009 Oct; 10(9):961-6. PubMed ID: 19410508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modafinil for narcolepsy: systematic review and meta-analysis.
    Golicki D; Bala MM; Niewada M; Wierzbicka A
    Med Sci Monit; 2010 Aug; 16(8):RA177-86. PubMed ID: 20671626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modafinil improves real driving performance in patients with hypersomnia: a randomized double-blind placebo-controlled crossover clinical trial.
    Philip P; Chaufton C; Taillard J; Capelli A; Coste O; Léger D; Moore N; Sagaspe P
    Sleep; 2014 Mar; 37(3):483-7. PubMed ID: 24587570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
    Nishino S; Kanbayashi T
    Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin-/- mice and patients.
    Lin JS; Dauvilliers Y; Arnulf I; Bastuji H; Anaclet C; Parmentier R; Kocher L; Yanagisawa M; Lehert P; Ligneau X; Perrin D; Robert P; Roux M; Lecomte JM; Schwartz JC
    Neurobiol Dis; 2008 Apr; 30(1):74-83. PubMed ID: 18295497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Narcolepsy: treatment issues.
    Roth T
    J Clin Psychiatry; 2007; 68 Suppl 13():16-9. PubMed ID: 18078361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacologic Management of Excessive Daytime Sleepiness.
    Takenoshita S; Nishino S
    Sleep Med Clin; 2020 Jun; 15(2):177-194. PubMed ID: 32386693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attention-Deficit/Hyperactivity Disorder (ADHD) Symptoms in Pediatric Narcolepsy: A Cross-Sectional Study.
    Lecendreux M; Lavault S; Lopez R; Inocente CO; Konofal E; Cortese S; Franco P; Arnulf I; Dauvilliers Y
    Sleep; 2015 Aug; 38(8):1285-95. PubMed ID: 26118560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.